tiprankstipranks
Zymeworks (ZYME)
NASDAQ:ZYME
US Market
ZYME
Zymeworks
RESEARCH TOOLSreports
Want to see ZYME full AI Analyst Report?

Zymeworks (ZYME) Stock News & Sentiment

625 Followers
Zymeworks Earnings Call Balances Promise and Risk
Premium
Company Announcements
Zymeworks Earnings Call Balances Promise and Risk
9d ago
ZYME
Zymeworks Authorizes 2026 Share Repurchase Program, Affirms Liquidity
Premium
Company Announcements
Zymeworks Authorizes 2026 Share Repurchase Program, Affirms Liquidity
14d ago
8K
ZYME
Zymeworks Maintained at Buy as Analyst Highlights Cash Runway, Upcoming Catalysts and Reiterates $46 Price Target
Premium
Ratings
Zymeworks Maintained at Buy as Analyst Highlights Cash Runway, Upcoming Catalysts and Reiterates $46 Price Target
17d ago
ZYME
Zymeworks’ Earnings Call Balances Progress And Pressure
Premium
Company Announcements
Zymeworks’ Earnings Call Balances Progress And Pressure
20d ago
ZYME
Zymeworks: Strong Ziihera Royalty Momentum and Deep Oncology Pipeline Underpin Buy Rating and Favorable Risk-Reward
Premium
Ratings
Zymeworks: Strong Ziihera Royalty Momentum and Deep Oncology Pipeline Underpin Buy Rating and Favorable Risk-Reward
21d ago
ZYME
Zymeworks Reports Q1 2026 Results and Pipeline Progress
Premium
Company Announcements
Zymeworks Reports Q1 2026 Results and Pipeline Progress
21d ago
8K
ZYME
Zymeworks: Buy Rating Reiterated as Priority Review for Zanidatamab Supports Upside; $46 Price Target Maintained
Premium
Ratings
Zymeworks: Buy Rating Reiterated as Priority Review for Zanidatamab Supports Upside; $46 Price Target Maintained
1M ago
ZYME
More ZYME News >

ZYME News on the Web

Citizens biotech analysts hold a dinnermeeting at ASCO
TipRanks News
Neutral
Zymeworks Earnings Call Balances Promise and Risk
TipRanks News
Neutral
Zymeworks authorizes share repurchase program of up to $125M
TipRanks News
Bullish
Zymeworks Authorizes 2026 Share Repurchase Program, Affirms Liquidity
TipRanks News
Neutral
Zymeworks Maintained at Buy as Analyst Highlights Cash Runway, Upcoming Catalysts and Reiterates $46 Price Target
TipRanks News
Bullish
Citi Reaffirms Their Buy Rating on Zymeworks (ZYME)
TipRanks News
Bullish
Zymeworks Q1 Earnings Call Highlights
MarketBeat
Bullish
Zymeworks’ Earnings Call Balances Progress And Pressure
TipRanks News
Neutral

News Score - Last 7 Days

Neutral
ZYME
Sector Average
Media Buzz
This Week1 articles
Weekly Average4.25 articles
News Sentiment
This Week59%
Sector Average79%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is ZYME’s Media Buzz Sentiment?
1 articles about ZYME were published this week. In an average week, 4.25 articles are published.
    What is ZYME’s weekly average amount of articles?
    In an average week, 4.25 articles about ZYME are published.
      What is ZYME’s News Sentiment?
      59% of articles about ZYME were positive this week, compared to its sector average of 79%.
        Healthcare Stocks that are Trending in the News
        AKTXAkari Therapeutics
        IMMXImmix Biopharma
        SYSo-Young International
        ADOAnteoTech Ltd
        FSPKFFisher & Paykel Healthcare Corporation Limited
        Showing the stocks with the most bullish news sentiment over the past week